This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Quintela, M. Articles by Diéguez, C. Search for Related Content PubMed PubMed Citation Articles by Quintela, M. Articles by Diéguez, C.

Transforming Growth Factor-ßs Inhibit Somatostatin Messenger Ribonucleic Acid Levels and Somatostatin Secretion in Hypothalamic Cells in Culture¹

Department of Physiology, Faculty of Medicine. University of Santiago de Compostela, Santiago de Compostela, Spain 15700

Address all correspondence and requests for reprints to: C. Diéguez, Departament of Physiology, Faculty of Medicine, University of Santiago de Compostela, 15700 Santiago de Compostela, Spain.

Treatment of hypothalamic cells in monolayer culture with transforming growth factor-ß1 (TGFß1) significantly reduced both basal and cAMP-induced somatostatin messenger RNA (mRNA) levels and somatostatin secretion. This inhibitory effect was dose- and time-dependent and not mediated by glial cells, as it was also observed in glial-free hypothalamic cell cultures treated with cytosine arabinonucleoside. TGFß2 and -ß3 mimicked the actions of TGFß1, which indicated that the three isoforms of the TGFß family expressed in the central nervous system displayed similar effects on the somatostatinergic neurons.

The blockade of synthesis of proteins with either cycloheximide or puromycin for 24 h prevented the inhibitory effect of TGFß1 on somatostatin mRNA. This implied that the reduction of this mRNA by TGFß1 required de novo protein synthesis.

We next studied whether TGFß1 acted at the transcriptional or posttranscriptional level by altering the stability of somatostatin mRNA. Examination of the rate of disappearance of somatostatin mRNA by Northern blot, after inhibition of mRNA transcription with either actinomycin D (AcD) or 5,6-dichloro-1ß-ribofuranosyl benzimidazole revealed that TGFß1 did reduce the stability of somatostatin mRNA. This effect was observed when we pretreated the cultures with TGFß1 4 h before the addition of AcD, but not when we administered TGFß1 simultaneously with AcD or 5,6-dichloro-1ß-ribofuranosyl benzimidazole.

Altogether these results demonstrated that the treatment of hypothalamic cells in culture with TGFß1, TGFß2, or TGFß3 resulted in a decrease in somatostatin mRNA levels and somatostatin secretion. TGFß1 reduced the steady state levels of somatostatin mRNA by inducing the synthesis of a protein (s), that appears to accelerate the degradation of the mRNA of somatostatin. Whether TGFß1 has additional effects on the transcription of the somatostatin gene will require further study.

This article has been cited by other articles:

				H. A. Hofmann and R. D. Fernald Social Status Controls Somatostatin Neuron Size and Growth J. Neurosci., June 15, 2000; 20(12): 4740 - 4744. [Abstract] [Full Text] [PDF]

				B. Lee, J.-C. Jonas, G. C. Weir, and S. G. Laychock Glucose Regulates Expression of Inositol 1,4,5-Trisphosphate Receptor Isoforms in Isolated Rat Pancreatic Islets Endocrinology, May 1, 1999; 140(5): 2173 - 2182. [Abstract] [Full Text]